Conceivable Life Sciences, which makes a robotic lab that can create human embryos, raised $50 million to help develop and launch its technology commercially at more in-vitro fertilization clinics with an aim to make it available in the US early next year.
Sarah Frier is an Editor in charge of Big Tech coverage at Bloomberg. She focuses on themes such as artificial intelligence, machine learning, and their implications on the global economy, with particular interest in AI platforms, computer vision, generative AI, natural language processing, and robotics. Frier's work has been featured in prominent publications including The Washington Post, Fortune, and TIME.

















